CTOs on the Move

MedSpeed

www.medspeed.com

 
Healthcare is changing. Healthcare organizations are growing. Care continues to expand outside of the hospital walls. This provides more capacity to utilize scale to create healthcare companies that are better functioning, smarter organizations. Intra-company logistics - the enterprise-wide movement of physical materials, such as blood and specimens, pharmaceuticals and supplies - is the foundation of the healthcare supply chain. Healthcare organizations, especially those providing service to patients` homes, need transportation to function. With 130+ locations in 29 states, MedSpeed is the market-leading organization that is changing the way the healthcare industry views transportation by leveraging it to help organizations integrate ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.medspeed.com
  • 140 Industrial Drive
    Elmhurst, IL USA 60126
  • Phone: 630.617.5050

Executives

Name Title Contact Details
Jim Van Duyn
Chief Information Officer Profile

Similar Companies

Sigma Telemed

Sigma Telemed is a York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AGS Health

AGS Health is an analytics-driven, technology-enabled revenue cycle management company serving leading healthcare providers across the U.S. AGS Health partners with clients to tackle RCM data challenges; advising them on what questions to ask and helping them find answers.

Summus Global

Summus Global, the leading virtual specialist platform, empowers families by providing access to a network of 4,000+ top specialists across 48 leading hospitals -- within days, from anywhere in the world.

BDI Pharma

BDI Pharma is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardionomic

Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.